25033-74-3

Basic information

• Product Name: 6-methyl-5-nitropyridine-2-carbaldehyde
• Synonyms: 6-methyl-5-nitropyridine-2-carbaldehyde;6-METHYL-5-NITROPICOLINALDEHYDE
• CAS NO: 25033-74-3
• Molecular Formula: C7H6N2O3
• Molecular Weight: 166.13414
• Mol File: 25033-74-3.mol

Chemical Properties

• Boiling Point: 288.2°C at 760 mmHg
• Flash Point: 128.1°C
• Appearance: /
• Density: 1.356g/cm³
• Vapor Pressure: 0.00238mmHg at 25°C
• Refractive Index: 1.61
• CAS DataBase Reference: 6-methyl-5-nitropyridine-2-carbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 6-methyl-5-nitropyridine-2-carbaldehyde(25033-74-3)
• EPA Substance Registry System: 6-methyl-5-nitropyridine-2-carbaldehyde(25033-74-3)

Safety Data

• Hazardous Substances Data: 25033-74-3(Hazardous Substances Data)

Usage

InChI:InChI=1/C7H6N2O3/c1-5-7(9(11)12)3-2-6(4-10)8-5/h2-4H,1H3

Upstream product

• 15513-52-7 3-nitro-2,6-lutidine 

Downstream Products

• 1419601-20-9 1-((1-(3-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)methyl)-3-(6-(hydroxymethyl)-2-methylpyridin-3-yl)urea 
• 1419604-54-8 1-(6-((tert-butyldimethylsilyloxy)methyl)-2-methylpyridin-3-yl)-3-((1-(3-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)methyl)urea 
• 1419604-52-6 phenyl 6-((tert-butyldimethylsilyloxy)methyl)-2-methylpyridin-3-ylcarbamate 
• 13603-40-2 (6-methyl-5-nitropyridin-2-yl)methanol 

Relevant articles and documents

Spectrophotometric and polarographic studies on the kinetics of hydrolysis of N-(6-methyl-5-nitropyridin-2-yl methylidene)-N′-(substituted thiazol-2-yl)hydrazines

The kinetics of the hydrolysis of hydrazpne derived from nitropyridine 2-carboxaldehyde and 2-hydrazino-4-substituted thiazoles la-e in 10% (v/v) DMF-buffer mixture has been investigated by applying two independent and different techniques viz UV-spectrop

Therapeutically Active Thiazolo-Pyrimidine Derivatives

A series of thiazolo[5,4-d]pyrimidine derivatives of formula (I) or an N-oxide thereof, or a pharmaceutically acceptable salt or solvate thereof: (I) Q represents a group of formula (Qa), (Qb), (Qc), (Qd) or (Qe) are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases; and organ and cell transplant rejection.

SUBSTITUTED HETEROAROMATIC PYRAZOLE-CONTAINING CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS

The invention relates to substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands

Substituted heteroaromatic pyrazole-containing carboxamide and urea compounds as vanilloid receptor ligands, pharmaceutical compositions containing these compounds and also to a method of using these compounds for treating and/or inhibiting pain and further diseases and/or disorders.

THERAPEUTICALLY ACTIVE THIAZOLO-PYRIMIDINE DERIVATIVES

A series of thiazolo[5,4-d]pyrimidine derivatives of formula (I) or an N-oxide thereof, or a pharmaceutically acceptable salt or solvate thereof: (I) Q represents a group of formula (Qa), (Qb), (Qc), (Qd) or (Qe) are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases; and organ and cell transplant rejection.

Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto

The present invention relates to certain substituted pyridinyl and pyrimidinyl derivatives of Fomula (Ia) that are modulators of metabolism. Accordingly, compounds of the present invention are useful in the treatment of metabolic-related disorders and com